{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:49:31Z","timestamp":1787698171811,"version":"build-2784847793"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Medical Research Project of Jiangsu Provincial Health Committee","award":["H2019003"],"award-info":[{"award-number":["H2019003"]}]},{"name":"Qinglan Project of Jiangsu Province"},{"name":"Jiangsu Teacher Letter"},{"name":"Natural Science Foundation of Jiangsu Health Vocational College","award":["JKA201814"],"award-info":[{"award-number":["JKA201814"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,21]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recombinant human erythropoietin (rh-EPO) has been shown to stimulate neurogenesis and angiogenesis, both of which play crucial roles in the repair of brain injuries. Previously, we observed that rh-EPO treatment effectively reduced brain damage and enhanced angiogenesis in a neonatal rat model of periventricular white matter damage (PWMD). The objective of this research is to investigate the specific mechanism through which rh-EPO regulates angiogenesis following PWMD in premature neonates. We conducted experiments utilizing a neonatal PWMD model. Following rh-EPO treatment, the levels of erythropoietin receptor (EPOR) were found to be increased in the damaged brain of rats. Although the total amount of extracellular signal-regulated kinase (ERK), a downstream protein in the EPO signaling pathway, remained unchanged, there was clear upregulation of phosphorylated ERK1 (p-ERK1) levels. The increase in levels of p-ERK1 was inhibited by an ERK kinase inhibitor, while the total amount of ERK remained unchanged. Conversely, the levels of EPOR were not affected by the inhibitor. Notably, the introduction of rh-EPO led to a significant increase in the frequency of angiogenesis-related cells and the expression levels of angiogenic factors. However, these effects were nullified when the ERK pathway was blocked. These findings indicate that rh-EPO enhances angiogenic responses through the EPOR-ERK1 pathway in a neonatal PWMD model.<\/jats:p>","DOI":"10.1093\/jnen\/nlae001","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T03:13:48Z","timestamp":1706066028000},"page":"161-167","source":"Crossref","is-referenced-by-count":4,"title":["Angiogenic responses are enhanced by recombinant human erythropoietin in a model of periventricular white matter damage of neonatal rats through EPOR-ERK1 signaling"],"prefix":"10.1093","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2535-6770","authenticated-orcid":false,"given":"Lihua","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, Jiangsu Health Vocational College , Nanjing 211800, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichao","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Danyang People\u2019s Hospital Affiliate of Nantong University , Danyang 212300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Danyang People\u2019s Hospital Affiliate of Nantong University , Danyang 212300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxian","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Jiangsu Health Vocational College , Nanjing 211800, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Zhongda Hospital, Southeast University , Nanjing 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"2024032523554491600_nlae001-B1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1871527321666220223092905","article-title":"Brain damage in the preterm infant: Clinical aspects and recent progress in the prevention and treatment","volume":"22","author":"Xie","year":"2023","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2024032523554491600_nlae001-B2","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/S2214-109X(18)30451-0","article-title":"Global, regional, and national estimates of levels of preterm birth in 2014: A systematic review and modelling analysis","volume":"7","author":"Chawanpaiboon","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2024032523554491600_nlae001-B3","doi-asserted-by":"crossref","first-page":"116702","DOI":"10.1016\/j.neuroimage.2020.116702","article-title":"Altered local cerebellar and brainstem development in preterm infants","volume":"213","author":"Wu","year":"2020","journal-title":"Neuroimage"},{"key":"2024032523554491600_nlae001-B4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pediatrneurol.2017.05.013","article-title":"Confusions in nomenclature: \u201cPeriventricular leukomalacia\u201d and \u201cwhite matter injury\u201d\u2014Identical, distinct, or overlapping?","volume":"73","author":"Volpe","year":"2017","journal-title":"Pediatr Neurol"},{"key":"2024032523554491600_nlae001-B5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/s41390-022-02232-3","article-title":"Neurodevelopmental consequences of preterm punctate white matter lesions: A systematic review","volume":"93","author":"de Bruijn","year":"2023","journal-title":"Pediatr Res"},{"key":"2024032523554491600_nlae001-B6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ijgo.13195","article-title":"Global burden of preterm birth","volume":"150","author":"Walani","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"2024032523554491600_nlae001-B7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2105\/AJPH.2019.305287","article-title":"Preterm birth in China between 2015 and 2016","volume":"109","author":"Chen","year":"2019","journal-title":"Am J Public Health"},{"key":"2024032523554491600_nlae001-B8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00401-017-1718-6","article-title":"White matter injury in the preterm infant: Pathology and mechanisms","volume":"134","author":"Back","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2024032523554491600_nlae001-B9","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/jcbfm.2008.32","article-title":"Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF","volume":"28","author":"Wang","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"2024032523554491600_nlae001-B10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3171\/2009.9.JNS09844","article-title":"Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: Comparison of treatment with single and triple dose","volume":"113","author":"Xiong","year":"2010","journal-title":"J Neurosurg"},{"key":"2024032523554491600_nlae001-B11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/156720205774962683","article-title":"Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity","volume":"2","author":"Chong","year":"2005","journal-title":"Curr Neurovasc Res"},{"key":"2024032523554491600_nlae001-B12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20021067","article-title":"Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis","volume":"198","author":"Villa","year":"2003","journal-title":"J Exp Med"},{"key":"2024032523554491600_nlae001-B13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12031-017-0937-6","article-title":"rhEPO enhances cellular anti-oxidant capacity to protect long-term cultured aging primary nerve cells","volume":"62","author":"Wang","year":"2017","journal-title":"J Mol Neurosci"},{"key":"2024032523554491600_nlae001-B14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/antiox11040652","article-title":"Erythropoietin as a neuroprotective drug for newborn infants: Ten years after the first use","volume":"11","author":"Perrone","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"2024032523554491600_nlae001-B15","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.sjbs.2020.05.040","article-title":"Therapeutic effect of erythropoietin on brain injury in premature mice with intrauterine infection","volume":"27","author":"Liu","year":"2020","journal-title":"Saudi J Biol Sci"},{"key":"2024032523554491600_nlae001-B16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jpeds.2011.12.052","article-title":"Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?","volume":"160","author":"Robertson","year":"2012","journal-title":"J Pediatr"},{"key":"2024032523554491600_nlae001-B17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1515\/jpm-2018-0360","article-title":"Erythropoietin in perinatal hypoxic-ischemic encephalopathy: A systematic review and meta-analysis","volume":"47","author":"Razak","year":"2019","journal-title":"J Perinat Med"},{"key":"2024032523554491600_nlae001-B18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jpeds.2015.02.052","article-title":"Safety of early high-dose recombinant erythropoietin for neuroprotection in very preterm infants","volume":"167","author":"Fauch\u00e8re","year":"2015","journal-title":"J Pediatr"},{"key":"2024032523554491600_nlae001-B19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A randomized trial of erythropoietin for neuroprotection in preterm infants","volume":"382","author":"Juul","year":"2020","journal-title":"N Engl J Med"},{"key":"2024032523554491600_nlae001-B20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1152\/japplphysiol.00800.2018","article-title":"Dose-dependent exacerbation of ventilation-induced lung injury by erythropoietin in preterm newborn lambs","volume":"126","author":"Allison","year":"2019","journal-title":"J Appl Physiol (1985)"},{"key":"2024032523554491600_nlae001-B21","doi-asserted-by":"crossref","first-page":"F45","DOI":"10.1136\/adc.2010.187344","article-title":"An association between infantile haemangiomas and erythropoietin treatment in preterm infants","volume":"97","author":"Doege","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2024032523554491600_nlae001-B22","first-page":"2318","article-title":"The effects of monotherapy with erythropoietin in neonatal hypoxic-ischemic encephalopathy on neurobehavioral development: A systematic review and meta-analysis","volume":"25","author":"Liu","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2024032523554491600_nlae001-B23","doi-asserted-by":"crossref","first-page":"1759091419871420","DOI":"10.1177\/1759091419871420","article-title":"Erythropoietin as a neuroprotective molecule: An overview of its therapeutic potential in neurodegenerative diseases","volume":"11","author":"Rey","year":"2019","journal-title":"ASN Neuro"},{"key":"2024032523554491600_nlae001-B24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/s41467-020-15041-1","article-title":"Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin","volume":"11","author":"Wakhloo","year":"2020","journal-title":"Nat Commun"},{"key":"2024032523554491600_nlae001-B25","doi-asserted-by":"crossref","first-page":"dev190249","DOI":"10.1242\/dev.190249","article-title":"Endogenous erythropoietin signaling regulates migration and laminar positioning of upper-layer neurons in the developing neocortex","volume":"147","author":"Constanthin","year":"2020","journal-title":"Development"},{"key":"2024032523554491600_nlae001-B26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.biopha.2016.12.115","article-title":"Neuroprotective effects of erythropoietin against sevoflurane-induced neuronal apoptosis in primary rat cortical neurons involving the EPOR-Erk1\/2-Nrf2\/Bach1 signal pathway","volume":"87","author":"Zhang","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"2024032523554491600_nlae001-B27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijpharm.2011.10.058","article-title":"Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia","volume":"422","author":"Wang","year":"2012","journal-title":"Int J Pharm"},{"key":"2024032523554491600_nlae001-B28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000362262","article-title":"Recombinant human erythropoietin augments angiogenic responses in a neonatal rat model of cerebral unilateral hypoxia-ischemia","volume":"106","author":"Zhu","year":"2014","journal-title":"Neonatology"},{"key":"2024032523554491600_nlae001-B29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2017.03.024","article-title":"Recombinant human erythropoietin offers neuroprotection through inducing endogenous erythropoietin receptor and neuroglobin in a neonatal rat model of periventricular white matter damage","volume":"650","author":"Zhu","year":"2017","journal-title":"Neurosci Lett"},{"key":"2024032523554491600_nlae001-B30","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1113\/JP271376","article-title":"Differential short-term regional effects of early high dose erythropoietin on white matter in preterm lambs after mechanical ventilation","volume":"594","author":"Barton","year":"2016","journal-title":"J Physiol"},{"key":"2024032523554491600_nlae001-B31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3389\/fneur.2020.00804","article-title":"Repetitive erythropoietin treatment improves long-term neurocognitive outcome by attenuating hyperoxia-induced hypomyelination in the developing brain","volume":"11","author":"Dewan","year":"2020","journal-title":"Front Neurol"},{"key":"2024032523554491600_nlae001-B32","first-page":"90","article-title":"[Relationship between injury time and expressions of EPO and its receptors in rats brain after cerebral injury]","volume":"32","author":"Li","year":"2016","journal-title":"Fa Yi Xue Za Zhi"},{"key":"2024032523554491600_nlae001-B33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2006.09.053","article-title":"Ischemic preconditioning-induced activation of ERK1\/2 in the rat hippocampus","volume":"409","author":"Choi","year":"2006","journal-title":"Neurosci Lett"},{"key":"2024032523554491600_nlae001-B34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbi.2009.10.017","article-title":"Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration","volume":"24","author":"van Velthoven","year":"2010","journal-title":"Brain Behav Immun"},{"key":"2024032523554491600_nlae001-B35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jvs.2013.06.054","article-title":"Potential role of erythropoietin receptors and ligands in attenuating apoptosis and inflammation in critical limb ischemia","volume":"60","author":"Joshi","year":"2014","journal-title":"J Vasc Surg"},{"key":"2024032523554491600_nlae001-B36","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3390\/ijms18071519","article-title":"Erythropoietin and its angiogenic activity","volume":"18","author":"Kim\u00e1kov\u00e1","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2024032523554491600_nlae001-B37","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1182\/blood-2014-11-575357","article-title":"Emerging EPO and EPO receptor regulators and signal transducers","volume":"125","author":"Kuhrt","year":"2015","journal-title":"Blood"},{"key":"2024032523554491600_nlae001-B38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2174\/1570159X19666210524154519","article-title":"Whether erythropoietin can be a neuroprotective agent against premature brain injury: Cellular mechanisms and clinical efficacy","volume":"20","author":"Ma","year":"2022","journal-title":"Curr Neuropharmacol"},{"key":"2024032523554491600_nlae001-B39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.yexcr.2017.11.002","article-title":"Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR\/JAK2-STAT3 pathway","volume":"361","author":"Wei","year":"2017","journal-title":"Exp Cell Res"},{"key":"2024032523554491600_nlae001-B40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/iovs.61.10.23","article-title":"Signaling through the erythropoietin receptor affects angiogenesis in retinovascular disease","volume":"61","author":"Bretz","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024032523554491600_nlae001-B41","doi-asserted-by":"crossref","first-page":"3723762","DOI":"10.1155\/2016\/3723762","article-title":"PD98059 protects brain against cells death resulting from ROS\/ERK activation in a cardiac arrest rat model","volume":"2016","author":"Nguyen","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"2024032523554491600_nlae001-B42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.transproceed.2016.01.009","article-title":"Erythropoietin receptor activation protects the kidney from ischemia\/reperfusion-induced apoptosis by activating ERK\/p53 signal pathway","volume":"48","author":"Zou","year":"2016","journal-title":"Transplant Proc"},{"key":"2024032523554491600_nlae001-B43","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1089\/neu.2008.0733","article-title":"Correlation of CD34(+) cells with tissue angiogenesis after traumatic brain injury in a rat model","volume":"26","author":"Guo","year":"2009","journal-title":"J Neurotrauma"},{"key":"2024032523554491600_nlae001-B44","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s11095-013-1076-6","article-title":"Co-delivery of vascular endothelial growth factor and angiopoietin-1 using injectable microsphere\/hydrogel hybrid systems for therapeutic angiogenesis","volume":"30","author":"Shin","year":"2013","journal-title":"Pharm Res"},{"key":"2024032523554491600_nlae001-B45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2016.09.024","article-title":"Erythropoietin improves hypoxic-ischemic encephalopathy in neonatal rats after short-term anoxia by enhancing angiogenesis","volume":"1651","author":"Yan","year":"2016","journal-title":"Brain Res"},{"key":"2024032523554491600_nlae001-B46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12031-017-0885-1","article-title":"The anti-aging effect of erythropoietin via the ERK\/Nrf2-ARE pathway in aging rats","volume":"61","author":"Wu","year":"2017","journal-title":"J Mol Neurosci"},{"key":"2024032523554491600_nlae001-B47","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1167\/iovs.15-18093","article-title":"Erythropoietin protects retinal cells in diabetic rats through upregulating ZnT8 via activating ERK pathway and inhibiting HIF-1\u03b1 expression","volume":"56","author":"Xu","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024032523554491600_nlae001-B48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2141.1996.d01-1864.x","article-title":"Erythropoietin production by interstitial cells of hypoxic monkey kidneys","volume":"95","author":"Fisher","year":"1996","journal-title":"Br J Haematol"},{"key":"2024032523554491600_nlae001-B49","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/jnr.22702","article-title":"Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury","volume":"89","author":"Kato","year":"2011","journal-title":"J Neurosci Res"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/83\/3\/161\/56697306\/nlae001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/83\/3\/161\/56697306\/nlae001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:21:41Z","timestamp":1730982101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/83\/3\/161\/7585917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,1,23]]},"published-print":{"date-parts":[[2024,2,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlae001","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2024,1,23]]}}}